Argent Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2M Sell
181,688
-17,911
-9% -$1.44M 0.45% 55
2026
Q1
$17.3M Buy
+199,599
New +$19.1M 0.55% 48
2023
Q1
Sell
-5,632
Closed -$438K 147
2022
Q4
$438K Sell
5,632
-138,924
-96% -$11.3M 0.02% 119
2022
Q3
$11.7M Buy
144,556
+3,057
+2% +$275K 0.46% 52
2022
Q2
$12.7M Sell
141,499
-5,865
-4% -$594K 0.48% 54
2022
Q1
$16.4M Buy
147,364
+532
+0.4% +$56.2K 0.51% 46
2021
Q4
$15.2M Sell
146,832
-738
-0.5% -$85.5K 0.44% 54
2021
Q3
$18.5M Sell
147,570
-571
-0.4% -$73.9K 0.59% 44
2021
Q2
$18.4M Sell
148,141
-194
-0.1% -$24.4K 0.57% 48
2021
Q1
$17.5M Buy
148,335
+182
+0.1% +$21.3K 0.58% 44
2020
Q4
$17.4M Buy
148,153
+1,027
+0.7% +$113K 0.62% 45
2020
Q3
$15.3M Buy
+147,126
New +$14.8M 0.58% 45

Other funds holding MDT

Argent Capital Management's MDT Position: Q2 2026 in Review

Argent Capital Management reduced its Medtronic (MDT) stake by 9% in Q2 2026, selling an estimated $1.44M and leaving 181,688 shares worth $14.2M. The position accounts for 0.45% of the portfolio, ranked #55.

Argent Capital Management first reported a position in MDT in Q3 2020 and has held it in 12 quarters since. The position peaked at $18.5M in Q3 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Argent Capital Management held 181,688 shares of Medtronic worth $14.2M as of Q2 2026.
  • Argent Capital Management sold 17,911 Medtronic shares in Q2 2026, an estimated $1.44M.
  • Medtronic made up 0.45% of Argent Capital Management's portfolio in Q2 2026, its #55 holding.
  • Argent Capital Management first reported a position in Medtronic in Q3 2020 and has held it in 12 quarters since.
  • Argent Capital Management's Medtronic position peaked at $18.5M in Q3 2021.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Argent Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.